Cartesian Therapeutics, Inc.: revenue
| Value | {"amount": 2797000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T13:54:53.266878+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/35c65cc1-2435-4aaf-a2af-22b64f525d58
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-26-000064Retrieved: 2026-09-01T13:54:53.266878+02:00
Raw response sha256:
1a706a4a3075779870f74e28a93e529a…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/revenue/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/35c65cc1-2435-4aaf-a2af-22b64f525d58
History
- supersedes {"amount": 400000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001453687-26-000064)